Plain-English translation of NCT07476118 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new medication called to see how it works and whether it's safe in healthy adults who are overweight or have obesity. Researchers will give some participants the medication as under-the-skin injections and others a placebo (a non-active injection that looks the same), and track how their bodies respond over about 42 weeks.
There is a need for new treatment options to help people manage weight and improve their health. This medication is being studied to understand how it affects the body and whether it could be a safe option for people struggling with overweight or obesity.
If you enroll, you'll be randomly assigned to receive either the new medication or a placebo as under-the-skin injections. You'll visit the research clinic regularly over about 42 weeks so researchers can monitor your health, take blood samples, and check how the medication is affecting your body. Some participants will receive the active medication while others receive placebo, but neither you nor the researchers will know which group you're in.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States